Alyce C. Katayama quoted in article “Stakeholders Say New 340B Guidance Adds Red Tape”Modern Healthcare 08/28/15
Below is an excerpt:
According to Alyce Katayama, a partner at law firm Quarles and Brady, the draft guidance released by the Health Resources and Services Administration aims to limit the ability of non-covered organizations to prescribe discounted drugs for patients referred to them by providers covered in the program.
She adds that in some ways the agency has shifted away from previous guidance it provided.
“Now that we have this insight as to where HRSA might go with the guidance, I think it's just going to put everyone in limbo until it is finalized,” Katayama said. “People will be concerned about what they're doing; people who might have wanted to implement new programs will put those plans on hold because they don't know how this thing will turn out.”